Intangible Assets And Goodwill - Additional Information (Detail) $ in Thousands |
3 Months Ended | 6 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|---|
|
Jun. 11, 2025
USD ($)
Retail Dispensaries
|
Jun. 02, 2025 |
Jun. 30, 2025
USD ($)
|
Jun. 30, 2024
USD ($)
|
Jun. 30, 2025
USD ($)
|
Jun. 30, 2024
USD ($)
|
Dec. 31, 2024
USD ($)
|
|
| Amortization | $ 12,437 | $ 12,573 | $ 25,011 | $ 25,244 | |||
| Weighted average amortization period | 15 years | 10 years 2 months 8 days | |||||
| Goodwill net of accumulated impairment losses | 57,372 | $ 57,372 | $ 57,372 | ||||
| Goodwill impairment charge | 0 | 0 | |||||
| Intangible assets [Member] | |||||||
| Weighted average amortization period | 15 years | ||||||
| Goodwill net of accumulated impairment losses | $ 31,131 | $ 31,131 | $ 31,131 | ||||
| Consideration Paid | $ 10,500 | ||||||
| retail dispensaries | Retail Dispensaries | 3 | ||||||
| X | ||||||||||
- Definition Retail dispensaries No definition available.
|
| X | ||||||||||
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of contingent consideration recognized as part of consideration transferred in asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of accumulated impairment loss for asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|